Omega-3-carboxylic acids Completed Phase 3 Trials for Crohn's Disease (CD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00613197EPANOVA in Crohn's Disease, Study 1
NCT00074542An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease